Cannabis Extract Effects on Metabolic Parameters and Gut Microbiota Composition in a Mice Model of NAFLD and Obesity.
Journal
Evidence-based complementary and alternative medicine : eCAM
ISSN: 1741-427X
Titre abrégé: Evid Based Complement Alternat Med
Pays: United States
ID NLM: 101215021
Informations de publication
Date de publication:
2022
2022
Historique:
received:
08
04
2022
revised:
26
05
2022
accepted:
28
05
2022
entrez:
7
7
2022
pubmed:
8
7
2022
medline:
8
7
2022
Statut:
epublish
Résumé
Nonalcoholic fatty liver disease (NAFLD) is a major cause of chronic liver abnormalities and has been linked with metabolic syndrome hallmarks. Unfortunately, current treatments are limited. This work aimed to elucidate the effects of three cannabis extracts on metabolic alteration and gut microbiota composition in a mouse model of NAFLD and obesity. Male mice were fed with a high-fat diet (HFD) for 12 weeks. Following the establishment of obesity, the HFD-fed group was subdivided into HFD or HFD that was supplemented with one of three cannabis extracts (CN1, CN2, and CN6) for additional 8 weeks. Metabolic parameters together with intestinal microbiota composition were evaluated. Except for several minor changes in gene expression, no profound metabolic effect was found due to cannabis extracts addition. Nevertheless, marked changes were observed in gut microbiota diversity and composition, with CN1 and CN6 exhibiting microbial abundance patterns that are associated with more beneficial outcomes. Taken together, specific cannabis extracts' addition to an HFD results in more favorable modifications in gut microbiota. Although no marked metabolic effect was disclosed, longer treatments duration and/or higher extracts concentrations may be needed. More research is required to ascertain this conjecture and to establish the influence of various cannabis extracts on host health in general and NAFLD in particular.
Identifiants
pubmed: 35795290
doi: 10.1155/2022/7964018
pmc: PMC9251106
doi:
Types de publication
Journal Article
Langues
eng
Pagination
7964018Informations de copyright
Copyright © 2022 Gil Zandani et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest regarding the publication of this paper.
Références
PLoS One. 2017 Oct 19;12(10):e0186702
pubmed: 29049354
Food Funct. 2020 Mar 26;11(3):1946-1957
pubmed: 32154541
Sci Rep. 2021 Mar 9;11(1):5532
pubmed: 33750881
Nat Microbiol. 2018 Jan;3(1):8-16
pubmed: 29255284
Braz J Psychiatry. 2008 Sep;30(3):271-80
pubmed: 18833429
J Proteomics. 2018 Apr 15;177:112-123
pubmed: 29438851
Nutrients. 2020 May 19;12(5):
pubmed: 32438689
EBioMedicine. 2020 Jan;51:102590
pubmed: 31901868
Aliment Pharmacol Ther. 2015 Nov;42(9):1051-63
pubmed: 26304302
Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):11070-5
pubmed: 16033867
Int J Mol Sci. 2016 Apr 01;17(4):481
pubmed: 27043550
Expert Rev Gastroenterol Hepatol. 2015;9(8):1087-99
pubmed: 26082274
Gastroenterology. 2020 May;158(7):1851-1864
pubmed: 32061595
Nutrients. 2020 Jan 16;12(1):
pubmed: 31963247
J Mol Med (Berl). 2009 Jul;87(7):663-8
pubmed: 19290485
Metabolism. 2019 Mar;92:82-97
pubmed: 30502373
Nat Med. 2017 Jan;23(1):107-113
pubmed: 27892954
J Hepatol. 2015 Jun;62(6):1382-90
pubmed: 25595882
Nat Commun. 2016 Nov 14;7:13329
pubmed: 27841267
FEMS Microbiol Rev. 2020 Jul 1;44(4):454-489
pubmed: 32556166
Front Microbiol. 2018 Dec 14;9:3063
pubmed: 30619149
Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13145-50
pubmed: 25157157
Psychopharmacology (Berl). 2003 Feb;165(4):431-2; author reply 433-4
pubmed: 12491031
PLoS One. 2017 Apr 25;12(4):e0176416
pubmed: 28441459
Lancet Diabetes Endocrinol. 2019 Apr;7(4):313-324
pubmed: 30174213
Infect Immun. 2009 Oct;77(10):4668-78
pubmed: 19635824
Mol Nutr Food Res. 2017 Dec;61(12):
pubmed: 28940737
Cannabis Cannabinoid Res. 2020 Sep 02;5(3):202-214
pubmed: 32923658
Nutrition. 2021 Oct;90:111240
pubmed: 33931271
Microorganisms. 2019 Jun 16;7(6):
pubmed: 31208113
BMJ Open. 2012 Feb 24;2:e000494
pubmed: 22368296
Eur J Pharmacol. 1998 Jul 17;353(1):23-31
pubmed: 9721036
J Dermatol Sci. 2007 Feb;45(2):87-92
pubmed: 17157480
Cell Metab. 2015 Dec 1;22(6):971-82
pubmed: 26552345
J Biol Chem. 1957 May;226(1):497-509
pubmed: 13428781
J Hepatol. 2015 Apr;62(1 Suppl):S47-64
pubmed: 25920090
Curr Opin Biotechnol. 2018 Feb;49:140-147
pubmed: 28866243
Front Cell Infect Microbiol. 2021 Nov 22;11:757718
pubmed: 34881193
Gut. 2001 Feb;48(2):206-11
pubmed: 11156641
Cell Host Microbe. 2018 Jan 10;23(1):41-53.e4
pubmed: 29276170
Hepatology. 2013 Jul;58(1):120-7
pubmed: 23401313
Epidemiology. 2015 Jul;26(4):597-600
pubmed: 25978795
Microbiol Spectr. 2017 Jun;5(3):
pubmed: 28643627
Am J Epidemiol. 2011 Oct 15;174(8):929-33
pubmed: 21868374
J Pharmacol Exp Ther. 2006 Sep;318(3):1375-87
pubmed: 16728591
Dis Model Mech. 2019 Apr 30;12(5):
pubmed: 30971408
Mol Syst Biol. 2010 Jul;6:392
pubmed: 20664638
Front Nutr. 2021 Jul 28;8:680241
pubmed: 34395490
Science. 2019 Jul 26;365(6451):
pubmed: 31346040
Cells. 2020 Jan 10;9(1):
pubmed: 31936799
Hepatology. 2013 Feb;57(2):601-9
pubmed: 23055155
Nat Med. 2018 Jul;24(7):908-922
pubmed: 29967350
Anal Biochem. 2014 Dec 15;467:1-3
pubmed: 25193447